HIV Diagnosis Becomes Up To Three Times Faster Thanks To This Invention
Africa’s poorest and most vulnerable can benefit from simple HIV test which monitors disease progression, enabling governments to deliver comprehensive treatment programs.
Prof Debbie Glencross is Director and Principle Pathologist in the Flow Cytometry unit of the Department of Haematology at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa
Improving diagnostics in rural communitiesProf Debbie Glencross is Director and Principle Pathologist in the Flow Cytometry unit of the Department of Hematology at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa. Her breakthrough PLG (Pan-Leukocyte Gating) method is easy to use and requires no specialist training, unlike conventional techniques for CD4 monitoring. Effective HIV treatment relies on clinicians having an accurate CD4 count for a patient. However, in many parts of rural Africa, the equipment and infrastructure simply isn’t available to test patients, get their blood samples to a lab, and then report the results. As Glencross explained: “Our objective is to empower smaller community laboratories so that they can extend the availability of PLG to meet demand, while still meeting the testing standards required by the National Health Laboratory Service (NHLS).”
“By making the testing process much simpler, both money and time can be saved.”
Speeding up CD4 cell counting
When counting CD4 cells, large labs differentiate between the types of white blood cells, count them and then work out the number of CD4 cells in each millionth of a liter of blood. While accurate, this method can be laborious.
In contrast, rather going through the time-consuming and costly process of isolating individual antibodies, Glencross’s approach uses a mathematical equation. She realized that using the white cell count as a stable reference point would eliminate the need for additional quality control steps, while still maintaining standards.
Working in partnership for maximum benefitWith the help of Beckman Coulter Life Sciences the Glencross’s PLG test was developed to use in conjunction the Aquios CL Flow Cytometer a more compact flow cytometry analyzer. Together the two technologies form the Aquios PLG test, a simple cytometry flow test which uses a two-color, pre-optimized reagent and provides both CD4 percentages and absolute counts. Consequently, the test enables rural healthcare workers with limited training to carry out diagnostics in community-based laboratories.
“A compact laboratory instrument is now available that offers high quality, automated CD4 counts in the near-patient setting.”
Reporting time reduced by up to 300 per centiResource-poor communities not only save time, but also much needed healthcare costs. It was reported at a recent conference of the African Society of Laboratory Medicine that the time it took to report results when using the new test could be reduced by as much as 300% (with the median time down from 12-38 hours to just 4-13 hours)i. Glencross concluded: “The cost of our HIV/AIDS burden makes it essential that we find new and more cost effective ways of providing CD4 monitoring. The PLG test simplifies flow cytometry so that it can be carried out in these smaller labs nearer the patient. This reduces the turnaround time so that people can have their results more quickly- but without increasing costs.”
Timely TreatmentPreviously, blood samples had to be transported for several days to the larger flow cytometry centers. The combination of the simplified test and a powerful but compact analyzer changes this. Dr. Jeannine T. Holden, Beckman Coulter’s Director of Scientific Affairs, pointed out: “A compact laboratory instrument is now available that offers high quality, automated CD4 counts in the near-patient setting. The rapid turnaround time and ease of use enables doctors and patients to get results in well under an hour, so that timely treatment decisions can be made.”
“The rapid turnaround time and ease of use enables doctors and patients to get results in well under an hour, so that timely treatment decisions can be made.”
*Photos courtesy for Dr Charles Kiyaga and Professor D. Glencross
i Cassim N, Coetzee LM, Glencross DK (2014, 2015) Assessing the impact of implementing a Community CD4 Laboratory in a rural health district in South Africa. African Society of Laboratory Medicine: 1st International Conference. Cape Town and NHLS PathRED, Johannesburg.
ii Coetzee LM, Cassim N, Glencross DK. Implementation of a new 'community' laboratory CD4 service in a rural health district in South Africa extends laboratory services and substantially improves local reporting turnaround time. S Afr Med J. 2015;106(1):82-7.
iii 2016 Global Summary, WHO http://www.who.int/hiv/data/en/
REQUEST ADDITIONAL INFORMATION
Global Initiative to Support the Fight Against HIVThe CARES initiative was launched and driven by a social and civic responsibility to support the fight against HIV. Public and private partnerships are being explored to identify areas for Beckman Coulter Life Sciences to contribute for the broader purpose.
The CARES Initiative Supports the UNAIDS 90-90-90 TargetMore than 30 years after HIV first appeared, there are an estimated 37 million cases worldwide with nearly 70% of HIV+ patients living in Sb Saharan Africa followed by South East Asia, Latin America and Eastern Europe.
Uganda NHLS Lab Strengthening Pilot
Beckman Coulter Life Science and The CARES Initiative to fight HIV/AIDS has partnered with the Uganda National Health Laboratory Service within the Ministry of Health based in Kampala Uganda. The partnership was formed to support a laboratory strengthening Pilot. The Pilot will run 12 months.
New WHO Guidelines for HIV
New World Health Organization guidelines seek to find and protect those at greatest risk of advanced HIV disease. Counting the number of CD4 cells in a patient’s blood is the only accurate way of monitoring how well their immune system is working and predicting the progression of HIV.